CompoAtlas

Maternov transit de grossesse

Food supplement declared in France, declaration No 2022-1-1241, decision dated 26 January 2022

Maternov transit de grossesse is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
LABORATOIRES MAJORELLE
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Autre : Carré
Daily dose
2 carrés
Intended populations
Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Transit

Declaration 181702, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Ficus carica L.Faux fruitAutre extrait sec12.6 g
Triticum aestivum L.SonAutre extrait sec3.6 g
Prunus domestica L.FruitAutre extrait sec1 g

Other active ingredients

NamePer day
Fibres d'avoinenot declared

Additives

E414

Other ingredients

huile de tournesol, sirop de blé

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line